Skip to content

CoMo Pharma

Active Risk: not assessed
General partnershipfounded 2026incorporated this yearWilgendreef 40, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 1039.673.021
Summary

CoMo Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

History

On 1 July 2026, CoMo Pharma was incorporated as a General partnership by two natural persons.12 Guy Morel has served as non-statutory manager of the company since 2026.2

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 03-07-2026

Acts, filings and financial milestones

2026
03-07
State Gazette act Incorporation
Appointment: Guy Morel (non-statutory manager) · Founder · Partner13 facts ▸
  • Incorporation, 01-07-2026
  • Founder, Hannelore Cocquyt
  • Founder, Guy Morel
  • Partner, Hannelore Cocquyt (hoofdelijk aansprakelijke vennoot)
  • Partner, Guy Morel (hoofdelijk aansprakelijke vennoot)
  • Capital
  • Capital contribution, euro 5.000
  • Capital contribution, euro 5.000
  • Director appointment, Guy Morel (non-statutory manager)
  • Other statement, statutaire zaakvoerders bij oprichting, geen benoemd
  • Other statement, doel boven vermogensvoordeel aan vennoten, voor zover blijkt uit 12°
  • Pre-incorporation commitments, takeover, alle verbintenissen aangegaan in naam en voor rekening van vennootschap in oprichting door oprichters,vennoten en/of zaakvoerders
  • +1 further facts in this act
State Gazette act
1 of 1 act read